Updates on development of oral remdesivir formulations
Jubilant Pharmova subsidiary Jubilant Pharma has concluded safety and pharmacokinetic/absorption studies of a new oral formulation of remdesivir in animals
A forum for researchers, students and applicants in the field of cyclodextrin technology
Jubilant Pharmova subsidiary Jubilant Pharma has concluded safety and pharmacokinetic/absorption studies of a new oral formulation of remdesivir in animals
CAPSUGEL JAPAN INC filed a patent application which has been published recently (WO2021145296). The subject matter is a hard capsule improved